同济堂
  Investor Relations
    Directors and Executive Officers
    Corporate Governance
    Stock Information
    Financial Reports
    SEC Filings
    Events
    Analyst Coverage
    Shareholder Services
     Download Investor Kit
     IR Contact
 
  Investor Relations You are here: Home -- Investor Relations  
 
  Corporate Profile
Tongjitang Chinese Medicines Company is a vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing,marketing and selling of modernized traditional Chinese medicine in China. ...More>>
 
Exchange: NYSE (US Dollar)
Price: 4.041
Change: 0.059
Volume: 13575
Data as of: 11/20/2009 4:00pm
 
 
 
 
  Nov 18,2009 Tongjitang Chinese Medicines Company Reports Third Quarter 2......
 
 
  Nov 11,2009 Tongjitang Chinese Medicines Company to Announce Third Quart......
 
 
  Oct 12,2009 Tongjitang Chinese Medicines Repurchases 19.3 Million Ordina......
 
     
 
Date Format Title
Sep 16, 2009 Printer Friendly Version Presentation - Investor Conference September 2009
 
IR Contact
f
Ashley Ammon
Integrated Corporate Relations
Tel:1-203-682-8200
Email:ashley.ammon@icrinc.com